Search
for
Sort by
Research 91–120 of 1000+
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- An overview on 5α-reductase inhibitors
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- 9 Role of 5α-reductase in health and disease
- Alopecia - the search for novel agents continues
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- The roles of Wnt/β‐catenin pathway in tissue development and regenerative medicine
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Actions of 5α-reductase inhibitors on the epididymis
- Mechanism of action of herbs and their active constituents used in hair loss treatment
- Novel Clove Essential Oil Nanoemulgel Tailored by Taguchi’s Model and Scaffold-Based Nanofibers: Phytopharmaceuticals with Promising Potential as Cyclooxygenase-2 Inhibitors in External Inflammation
- In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5α-reductase inhibitors
- Hormone therapy in acne
- Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Chapter 23. Therapeutic Control of Androgen Action
- Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
- Effect of finasteride on the ovulatory function of normal women
- Steroid Hormones
- Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Cutaneous drug reactions
- Development of Stratum Corneum Lipid Liposomes for Topical Drug Delivery
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib